Advertisement
Screener

ImmuCell Corporation (ICCC) Long-term Line of Credit

2.0 / 5 stars · 44/111 Roast Me

ImmuCell Corporation Long-term Line of Credit

ImmuCell Corporation (ICCC) had Long-term Line of Credit of $1.00 million as of 2025-06-30, per its 10-Q filed 2025-08-14.

Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified

us-gaap:LineOfCredit · last filed 2025-08-14

  • 2025-06-30: Long-term Line of Credit $1.00M.
  • 2025-03-31: Long-term Line of Credit $1.00M.
  • 2024-12-31: Long-term Line of Credit $1.00M.
  • 2024-09-30: Long-term Line of Credit $1.00M.
Period endLong-term Line of Credit
2025-06-30$1.00M
10-Q · filed 2025-08-14
2025-03-31$1.00M
10-Q · filed 2025-05-14
2024-12-31$1.00M
10-K · filed 2025-03-28
2024-09-30$1.00M
10-Q · filed 2024-11-13
2020-03-31$1.00M
10-Q · filed 2025-08-14
2017-06-30$500.00K
10-Q · filed 2017-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92